FLU-v, developed by PepTcell (SEEK), is a peptide vaccine aiming to provide a broadly
protective cellular immune response against influenza A and B. A randomized, double-blind …

Background The relative vaccine effectiveness (rVE) of high-dose quadrivalent influenza
vaccines (QIV-HD) versus standard-dose quadrivalent influenza vaccines (QIV-SD) against …

Background. We estimated the effectiveness of inactivated influenza vaccines for the
prevention of laboratory-confirmed, medically attended influenza during 3 seasons with …

The current pandemic threat can be best understood within an ecological framework that
takes account of the history of past pandemics caused by influenza A, the relationships …

Influenza viruses, particularly influenza A viruses, cause a substantial degree of morbidity
and mortality worldwide and are a persistent threat to global health. Influenza viruses have 2 …

This report updates the 2012 recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of influenza vaccines for the prevention …

Homologous recombination between corresponding RNA segments of different influenza
viruses has not been observed, in contrast to the high frequency of recombination observed …

Live attenuated influenza vaccine (LAIV) is an intranasally administered trivalent, seasonal
influenza vaccine that contains three live influenza viruses (two type A [H1N1 and H3N2 …

Background We aimed to assess evidence of efficacy and effectiveness of live attenuated
and inactivated influenza vaccines in children up to 16 years of age. Methods We searched …

Background Seasonal influenza imposes a substantial personal morbidity and societal cost
burden. Vaccination is the major strategy for influenza prevention; however, because …